Pay in 4 interest-free payments of $5.61 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Under the expanded label, Imfinzi can be given with chemotherapy to NSCLC patients who have no known EGFR or ALK mutations
( Epub 2017/06/03 )
May 1 Product: Boehringer Ingelheims Cyltezo Indication: Rheumatoid arthritis, Crohns disease, ulcerative colitis and more Theres another new biosimilar option to AbbVies blockbuster antirheumatic Humira
You can do this by calling us on 01322 381 205, emailing us at [email protected] or WhatsApp us directly
US$ 23.88
US$ 24.35
US$ 24.59
US$ 25.13
US$ 28.57
